Events2Join

New targets for monitoring and therapy in Barth syndrome


New targets for monitoring and therapy in Barth syndrome - PubMed

We defined previously unrecognized metabolite/phenotype/genotype relationships, established targets for therapeutic monitoring, and validated avenues for ...

New targets for monitoring and therapy in Barth syndrome - Nature

Barth syndrome (BTHS), an X-linked disorder caused by defects in TAZ, is the only known single-gene disorder of cardiolipin remodeling.

New Targets for Monitoring and Therapy in Barth Syndrome : News ...

New Targets for Monitoring and Therapy in Barth Syndrome. PURPOSE: Barth syndrome (BTHS), an X-linked disorder caused by defects in TAZ, is the only known ...

New targets for monitoring and therapy in Barth syndrome. - Abstract

Barth syndrome (BTHS), an X-linked disorder caused by defects in TAZ, is the only known single-gene disorder of cardiolipin remodeling. We hypothesized that ...

New targets for monitoring and therapy in Barth syndrome ...

Barth syndrome (BTHS), an X-linked disorder caused by defects in TAZ, is the only known single-gene disorder of cardiolipin remodeling.

New targets for monitoring and therapy in Barth syndrome | Request ...

Request PDF | New targets for monitoring and therapy in Barth syndrome | Purpose: Barth syndrome (BTHS), an X-linked disorder caused by defects in TAZ, ...

New targets for monitoring and therapy in Barth syndrome - Toronto ...

Purpose: Barth syndrome (BTHS), an X-linked disorder caused by defects in TAZ , is the only known single-gene disorder of cardiolipin remodeling.

Researchers identify potential new drug target for treating Barth ...

Kagan, V. E., et al. (2023). Anomalous peroxidase activity of cytochrome c is the primary pathogenic target in Barth syndrome. Nature Metabolism ...

Elamipretide for Barth syndrome cardiomyopathy - PubMed Central

A more logical approach to the treatment of Barth syndrome cardiomyopathy is to target the underlying mitochondrial pathology of Barth syndrome that ...

October 10, 2024 Cardiovascular and Renal Drugs Advisory ... - FDA

the BarTH Syndrome Symptom Assessment (BTHA-SA). Page 13. 13. In ... Vernon, 2016, New targets for monitoring and therapy in Barth ...

elamipretide - Barth Syndrome Foundation

FDA Advisory Committee strongly recommends approval of elamipretide for treatment of Barth syndrome in a 10:6 vote. ... This timeline is constantly being updated.

Barth syndrome: A potential treatment for a rare disease

When TAFAZZIN is mutated, immature CL species accumulate, leading to the increased ratio of monolysocardiolipin (MLCL) to CL that is diagnostic ...

Current and future treatment approaches for Barth syndrome

More recently, two clinical trials were undertaken to target mitochondrial dysfunction in Barth syndrome. Bezafibrate and elamipretide each ...

October 10, 2024 Meeting of the Cardiovascular and Renal Drugs ...

"New targets for monitoring and therapy in Barth syndrome." Genetics in. Medicine 18, no. 10 (2016): 1001-1010. Thompson, R., Manuel, R ...

Clinical laboratory studies in Barth Syndrome - ScienceDirect

Barth Syndrome is a rare X-linked disorder characterized principally by dilated cardiomyopathy, skeletal myopathy and neutropenia and caused by defects in ...

FGF21 and GDF15 are elevated in Barth Syndrome and are ...

GDF-15 was significantly positively associated with NT-proBNP. We conclude that clinical measurements of FGF21 and GDF-15 may be relevant in the monitoring ...

Barth Syndrome Cardiomyopathy: An Update - MDPI

Barth syndrome (BTHS) is an X-linked mitochondrial lipid disorder caused by mutations in the TAFAZZIN (TAZ) gene, which encodes a mitochondrial acyltransferase ...

Full article: Barth syndrome: mechanisms and management

Objectives: Barth syndrome is an ultra-rare, infantile-onset, X-linked recessive mitochondrial disorder, primarily affecting males, due to variants in TAZ ...

Barth Syndrome Clinic | Kennedy Krieger Institute

Dedicated to finding and developing new treatments for this disorder, we led the first therapeutic clinical trial for Barth syndrome. ... goals. Related ...

New Targets for Monitoring and Therapy in Barth Syndrome

New Targets for Monitoring and Therapy in Barth Syndrome by W. Reid Thompson, Brittany DeCroes, Rebecca McClellan, Jessica Rubens, Frédéric M. Vaz,